BIOHAZARD Sample Clauses

BIOHAZARD. All cultured animal and human cells have the potential for carrying viruses, latent viral genomes, and other infectious agents in a latent or inactive state. NIGMS Repository Samples shipped by the Repository should therefore not be treated as if they are free of contamination. These NIGMS Repository Sample(s) should always be handled carefully by trained persons under laboratory conditions which afford adequate biohazard containment following MINIMUM SAFETY GUIDELINES RECOMMENDED FOR WORKING WITH HUMAN CELL CULTURES. By accepting NIGMS Repository Sample(s), the undersigned assume full responsibility for their safe and appropriate handling. We, the undersigned, have read and understand this document and agree to adhere to the restrictions and warnings stated herein. Name of Institution: Institutional Official who can make legal commitments on behalf of the Institution (typed or printed): Title of Institutional Official: Signature of Institutional Official: Date: Read and Understood the terms and conditions of this Agreement: Principal Investigator (typed or printed): Signature of Principal Investigator: Date: To contact the CORIELL CELL REPOSITORIES: Write: 000 Xxxxxx Xxxxxx, Xxxxxx, Xxx Xxxxxx 00000 XXX Call: 000-000-0000 in the United States; 000-000-0000 from other countries Fax: 000-000-0000
Sample 1Sample 2
AutoNDA by SimpleDocs
BIOHAZARD. All cultured animal and human cells as well as other human biological have the potential for carrying viruses, latent viral genomes, and other infectious agents in a latent or inactive state. NINDS Materials should therefore NOT be treated as if they are free of contamination. NINDS Materials should always be handled carefully by trained persons under laboratory conditions which afford adequate biohazard containment following MINIMUM SAFETY GUIDELINES RECOMMENDED FOR WORKING WITH HUMAN CELL CULTURES. By accepting the NINDS Materials, the undersigned assumes full responsibility for their safe and appropriate handling. Principal Investigator agrees to provide notice to the NHCDR of any containment or quality issues related to the NINDS Materials. WARRANTY AND LIABILITY Warranty: THE NHCDR MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. IN ADDITION, THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS. IN ADDITION THE REPOSITORY CUSTOMER ACKNOWLEDGES THAT THE MATERIAL MAY BE THE SUBJECT OF A PATENT APPLICATION OR COVERED BY PATENT RIGHTS IN ONE OR MORE COUNTRIES. EXCEPT AS PROVIDED IN THIS AGREEMENT, NO EXPRESS OR IMPLIED LICENSES TO SUCH PATENT RIGHTS ARE PROVIDED. UNLESS SPECIFICALLY STATED, NO LICENSE OR RIGHT TO USE ANY THIRD PARTY PATENT, TECHNOLOGY, OR INTELLECTUAL PROPERTY IS CONVEYED TO RECIPENT UNDER THIS AGREEMENT. IT IS THE SOLE RESPONSIBILITY OF THE RECIPIENT TO OBTAIN FROM THIRD PARTIES THAT MAY HAVE A PROPRIETARY INTEREST IN THE MATERIAL, OR MODIFICATIONS(ADDITION OR DELETION OF BIOLOGICAL COMPONENTS) OR DERIVATIVES THEREOF, ANY PERMISSIONS NECESSARY THAT ARE CONSISTENT WITH RECIPIENT'S INTENDED USE OF THE MATERIAL, MODIFICATIONS, OR DERIVATIVES. Liability Statement for Institutions Receiving NINDS Materials: Institution agrees to be responsible for any claims, costs, damages, or expenses resulting from any injury (including death), damage, or loss that may arise from its use or distribution of the NINDS Materials obtained under this agreement or any derivatives thereof to the extent permitted by law. Liability Statement for U.S. Government Laboratories Receiving NINDS Materials: Institution assumes the liability for any claims, damages, injuries, or expenses arising from its use of NINDS Materials or derivatives, but only to the extent provided ...
Sample 1
BIOHAZARD. All cultured animal and human cells have the potential for carrying viruses, latent viral genomes and other infectious agents in a latent or inactive state. Sample(s) shipped by the Autism Research Resource should therefore not be treated as if they are free of contamination. These Sample(s) should always be handled carefully by trained persons under laboratory conditions which afford adequate biohazard containment following MINIMUM SAFETY GUIDELINES RECOMMENDED FOR WORKING WITH BIOHAZARDS. By accepting these Sample(s), the undersigned assume full responsibility for their safe and appropriate handling. We, the undersigned, have read and understand this document and agree to adhere to the restrictions and warnings stated herein. Name of Institution Name of Institutional Official who can make legal commitments on behalf of the Institution (typed or printed) Title of Institutional Official Signature of Institutional Official Date Read and Understood the terms and conditions of this Agreement: Name of Principal Investigator (typed or printed) Signature of Principal Investigator Date Xxxxxxx Institute for Medical Research Institutional Official Date To contact the CORIELL CELL REPOSITORIES: Write: 000 Xxxxxx Xxxxxx, Xxxxxx, Xxx Xxxxxx 00000 XXX Call: 000-000-0000 in the United States; 000-000-0000 from other countries
Sample 1Sample 2
BIOHAZARD. Fruitometry will use industry best practise wash down techniques to minimise the likelihood of biohazard orchard cross-contamination. The Client will be required to advise Fruitometry if they have any special requirements to reduce biohazards.
Sample 1Sample 2
BIOHAZARD. All cultured animal and human cells as well as other human biological have the potential for carrying viruses, latent viral genomes, and other infectious agents in a latent or inactive state. NINDS Materials should therefore NOT be treated as if they are free of contamination. NINDS Materials should always be handled carefully by trained persons under laboratory conditions which afford adequate biohazard containment following MINIMUM SAFETY GUIDELINES RECOMMENDED FOR WORKING WITH HUMAN CELL CULTURES. By accepting the NINDS Materials, the undersigned assumes full responsibility for their safe and appropriate handling. Principal Investigator agrees to provide notice to the NINDS Repository of any containment or quality issues related to the NINDS Materials. WARRANTY AND LIABILITY Warranty: THE NINDS REPOSITORY MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. IN ADDITION, THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS. Liability Statement for State Institutions Receiving NINDS Materials: Institution agrees to be responsible for any claims, costs, damages, or expenses resulting from any injury (including death), damage, or loss that may arise from the use of the NINDS Materials to the extent permitted under the laws of the Institution’s state. This provision shall also apply to any derivatives of the NINDS Materials.
Sample 1
BIOHAZARD. Cultured human cells have the potential for carrying viruses, latent viral genomes, and other infectious agents in a latent or inactive state. Materials should therefore NOT be treated as if they are free of contamination. Materials should always be handled carefully by trained persons in accordance with good laboratory practices and under laboratory conditions that afford adequate biohazard containment following the guidelines published by the Centers for Disease Control and Prevention’s (CDC), which are accessible via the following link: xxxxx://xxx.xxx.xxx/biosafety/publications/bmbl5/index.htm. By accepting Materials, Principal Investigator assumes full responsibility for their safe and appropriate handling. Principal Investigator agrees to provide notice to the FCDI and the CIRM Repository of any containment or quality issues related to any Materials.
Sample 1
BIOHAZARD. All cultured animal and human cells have the potential for carrying viruses, latent viral genomes, and other infectious agents in an inapparent state. The cell cultures shipped by the Repository should therefore not be treated as if they are free of contamination. These cells should always be handled carefully by trained persons under laboratory conditions which afford adequate biohazard containment following MINIMUM SAFETY GUIDELINES RECOMMENDED FOR WORKING WITH HUMAN CELL CULTURES.
Sample 1
AutoNDA by SimpleDocs
BIOHAZARD. Cultured human cells have the potential for carrying viruses, latent viral genomes, and other infectious agents in a latent or inactive state. Materials should therefore NOT be treated as if they are free of contamination. Materials should always be handled carefully by trained persons under laboratory conditions that afford adequate biohazard containment following MINIMUM SAFETY GUIDELINES RECOMMENDED FOR WORKING WITH HUMAN CELL CULTURES, which guidelines can be obtained from Xxxxxxx upon request. By accepting the Materials, Institution assumes full responsibility for their safe and appropriate handling. Institution agrees to provide notice to the Coriell and the Repository of any containment or quality issues related to the Materials.
Sample 1
BIOHAZARD. Biological substances that pose a threat to the health of living organisms, primarily that of humans. This can include medical waste, bodily fluids or samples of a microorganism, virus or toxin (from a biological source) that can affect human health.
Sample 1

Related to BIOHAZARD

  • Safety Glasses 10.3.1 Where a teacher is considered to be working in an “eye danger” area, the teacher shall receive a personal issue of standard neutral safety glasses which shall remain the property of the employer.

  • Prescription Safety Glasses Prescription safety glasses will be furnished by the employer. The employer retains the authority to establish reasonable rules and procedures regarding frequency of issue, replacement of damaged glasses, limits on reimbursement costs and coordination with the employer's vision plan.

  • Medical Devices This Article applies when the Goods and/or Services involve UC purchasing or leasing one or more medical devices from Supplier, or when Supplier uses one or more medical devices in providing Goods and/or Services to UC. Medical Device as used herein will have the meaning provided by the U.S. Food and Drug Administration (“FDA”) and means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: (i) recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them; (ii) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (iii) intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes. Supplier warrants that prior to UC’s purchase or lease of any Medical Device or Supplier’s use of any Medical Device in providing Goods and/or Services hereunder, Supplier will: (i) perform security testing and validation for each such Goods and/or Services or Medical Device, as applicable; (ii) perform a security scan by an anti-virus scanner, with up-to-date signatures, on any software embedded within any Goods and/or Services or Medical Device, as applicable, in order to verify that the software does not contain any known viruses or malware; (iii) conduct a vulnerability scan encompassing all ports and fuzz testing; and (iv) provide UC with reports for (i) – (iii). Supplier warrants that all security testing performed by Supplier covers all issues noted in the “SANS WE TOP 25” and/or “OWASP Top 10” documentation. Throughout Supplier’s performance of this Agreement, Supplier will provide UC with reasonably up-to-date patches, firmware and security updates for any Medical Device provided to UC, and any other Medical Device used in the course of providing Services, as applicable. All such patches and other security updates will be made available to UC within thirty (30) days of its commercial release or as otherwise recommended by Supplier or Supplier’s sub-supplier, whichever is earlier. Supplier warrants that all software and installation media not specifically required for any Medical Device used by Supplier or Goods and/or Services delivered to UC under this Agreement as well as files, scripts, messaging services and data will be removed from all such Goods and/or Services or Medical Device following installation, and that all hardware ports and drives not required for use or operation of such Goods and/or Services or Medical Device will be disabled at time of installation. In addition, Medical Devices must be configured so that only Supplier-approved applications will run on such Medical Devices. Supplier agrees that UC may take any and all actions that it, in its sole discretion, deems necessary to address, mitigate and/or rectify any real or potential security threat, and that no such action, to the extent such action does not compromise device certification, will impact, limit, reduce or negate Supplier’s warranties or any of Supplier’s other obligations hereunder. Supplier warrants that any Medical Device provided to UC, and any other Medical Device used in the course of providing such Goods and/or Services, meet and comply with all cyber-security guidance and similar standards promulgated by the FDA and any other applicable regulatory body. If the Goods and/or Services entail provision or use of a Medical Device, Supplier will provide UC with a completed Manufacturer Disclosure Statement for Medical Device Security (MDS2) form for each such Medical Device before UC is obligated to purchase or lease such Medical Device or prior to Supplier’s use of such device in its performance of Services. If Supplier provides an MDS2 form to UC concurrently with its provision of Goods and/or Services, UC will have a reasonable period of time to review such MDS2 form, and if the MDS2 form is unacceptable to UC, then UC in its sole discretion may return the Goods or terminate the Agreement with no further obligation to Supplier.

  • Medication 1. Xxxxxxx’s physician shall prescribe and monitor adequate dosage levels for each Client.

  • Medical There shall be an open enrollment period for medical coverage in each year of this Agreement. An employee may elect no medical coverage during any open enrollment period. An employee who has elected no medical coverage may elect medical coverage during an open enrollment period. No pre-existing condition limitations will apply.

  • Waste Borrower shall not commit or suffer any waste of the Property or make any change in the use of the Property which will in any way materially increase the risk of fire or other hazard arising out of the operation of the Property, or take any action that might invalidate or give cause for cancellation of any Policy, or do or permit to be done thereon anything that may in any way impair the value of the Property or the security of this Security Instrument. Borrower will not, without the prior written consent of Lender, permit any drilling or exploration for or extraction, removal, or production of any minerals from the surface or the subsurface of the Land, regardless of the depth thereof or the method of mining or extraction thereof.

  • Workplace Safety Insurance 6.1 For the purposes of Article 41.2 (Workplace Safety & Insurance) of the Central Collective Agreement “sixty-five (65) working days” shall be deemed to be (471¼ or 520) hours.

  • Electrical appliance safety The Hirer shall ensure that any electrical appliances brought by them to the premises and used there shall be safe, in good working order, and used in a safe manner in accordance with the Electricity at Work Regulations 1989. Where a residual circuit breaker is provided the hirer must make use of it in the interests of public safety.

  • Labeling Upon request, Lessee will xxxx the Equipment indicating Lessor's interest with labels provided by Lessor. Lessee will keep all Equipment free from any other marking or labeling which might be interpreted as a claim of ownership.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

Time is Money Join Law Insider Premium to draft better contracts faster.